Abstract: Provided are organometallic compounds comprising an Ir atom as the central metal atom which is coordinated by two three-dentate ligands. Also provided are formulations comprising these organometallic compounds comprising an Ir atom. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds comprising an Ir atom.

Abstract: A compound having a formula of Ir(LA)n(LB)m(LC)o, wherein first ligand LA comprises a structure of Formula I, LB comprises a structure of Formula IIA, or Formula IIB, and LC is a bidentate ligand. In these structures, n is 1 or 2, m is 1 or 2, o is 0 or 1, and m+n+o=3; each of moiety A, moiety D, and moiety F is a monocyclic ring or polycyclic fused ring system; moiety B is a polycyclic fused ring system; each of Z1 to Z6 and X1 to X7 is C or N; Y1 is O, S, Se, Te, P, Si, and Ge; and each RA, RB, RC, RD, RE, and RF is hydrogen or a General Substituent. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound having the formula Ir(LA)n(LB)3-n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein each of A1 to A8 comprise carbon or nitrogen; wherein at least one of A1 to A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from a variety of substituents; wherein R3, R4, R5, and R6 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; wherein n is an integer from 1 to 3; and wherein total number of carbons in at least one of the pairs R3 and R4, and

Abstract: Novel ligands for metal complexes containg five-membered ring fused on pyridine or pyrimidine ring combined with partially fluorinated side chains exhibiting improved external quantum efficiency and lifetime are disclosed.

Abstract: Novel ligands for metal complexes containing five-membered ring fused on pyridine or pyrimidine ring combined with partially fluorinated side chains exhibiting improved external quantum efficiency and lifetime are disclosed.

Abstract: A compound having the formula Ir(LA)n(LB)3-n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein each of A1 to A8 comprise carbon or nitrogen; wherein at least one of A1 to A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from a variety of substituents; wherein R3, R4, R5, and R6 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; wherein n is an integer from 1 to 3; and wherein total number of carbons in at least one of the pairs R3 and R4, and

Abstract: A compound comprising a first ligand LA of Formula I, In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; X1, X2, and Z1 are C or N; Y1 is O, S, Se, Te, CRR?, SiRR?, GeRR?, PR, AsR, SbR, or BiR; K1 is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); each R, R?, R?, R?, RA, and RB is hydrogen or a general substituent; any two substituents may be joined or fused to form a ring; LA is coordinated to a metal M to form a 5-membered or 6-membered chelate ring; and two RB substituents join to form a 5-membered ring if Y1 is O, S, or Se. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: Provided are organometallic compounds comprising iridium as a central metal atom which is coordinated by two three-dentate ligands which each comprise at least three 5-membered or 6-membered rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound that has the structure according to Formula M(LA)x(LB)y(LC)z is disclosed. In Formula M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is and OLEDs and formulations containing these compounds are disclosed. In Formula M(LA)x(LB)y(LC)z; M is a metal; x is 1 or 2; X1-X4 and A1-A8 are C or N; at least one of A1-A8 is N; X is O, S, or Se; two adjacent RB form a six-member aromatic ring E fused to ring B; and each RA-RE and R1R4 is independently hydrogen or a substituent.

Abstract: This invention discloses iridium complexes with ligands based on a phenyl quinoline backbone with at least a double substitution on the quinoline moiety. These complexes can be used as phosphorescent emitters in OLEDs.

Abstract: A compound having a formula M(LA)x(LB)y(LC)z, where ligand LA is ligand LB is and ligand LC is is disclosed. In formula M(LA)x(LB)y(LC)z, M is a metal having an atomic number greater than 40; x is 1 or 2; y and z are independently 0, 1, or 2; x+y+z is the oxidation state of the metal M; A1-A8 are carbon or nitrogen; ring B is bonded to ring A through a C—C bond; M is bonded to ring A through a M-C bond; X is O, S, Se, CRR?, or NR1; rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; at least one R4 is a five-membered or six-membered heterocyclic ring which can be further substituted by RE; each R substituent is independently selected from the several substituents; and any adjacent R substitutents are optionally joined to form a ring.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: A compound having a formula M(LA)x(LB)y(LC)z, where ligand LA is ligand LB is and ligand LC is is disclosed. In formula M(LA)x(LB)y(LC)z, M is a metal having an atomic number greater than 40; x is 1 or 2; y and z are independently 0, 1, or 2; x+y+z is the oxidation state of the metal M; A1-A8 are carbon or nitrogen; ring B is bonded to ring A through a C—C bond; M is bonded to ring A through a M-C bond; X is O, S, Se, CRR?, or NR1; rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; at least one R4 is a five-membered or six-membered heterocyclic ring which can be further substituted by RE; each R substituent is independently selected from the several substituents; and any adjacent R substitutents are optionally joined to form a ring.

Abstract: Novel ligands for metal complexes that are useful as phosphorescent emitters in OLEDs are disclosed. The ligands contain an aryl covalently bonded to the coordinating metal where the aryl group has at least two different alkyl side chains that are linked ortho and para compared to the linkage of the coordinating metal on that aryl group.

Abstract: Novel ligands for metal complexes that are useful as phosphorescent emitters in OLEDs are disclosed. The ligands contain an aryl covalently bonded to the coordinating metal where the aryl group has at least two different alkyl side chains that are linked ortho and para compared to the linkage of the coordinating metal on that aryl group.

Abstract: A phosphorescent emitter compound having a first ligand LA having a Formula I, is disclosed. An OLED having the compound incorporated therein is also disclosed.

Abstract: A compound having the formula (LA)mIr(LB)3-m, where LA is and LB is is disclosed. In the formula (LA)mIr(LB)3-m, LA and LB are different; each of X1 to X5 is C—RF or nitrogen; X is selected from O, S, and Se; each R1, R2, RB, RD, and RF is hydrogen or a substituent; R3 is alkyl, cycloalkyl, or a combination thereof; and m is 1 or 2. OLEDs, consumer products, and formulations including the compound are also disclosed.

Abstract: A compound having the formula (LA)mIr(LB)3-m, where LA is and LB is selected from is disclosed. In the formula (LA)mIr(LB)3-m, LA and LB are different; each of X1 to X5 is C—RF or nitrogen; X is selected from O, S, and Se; each R1, R2, RB, RD, RE, and RF is hydrogen or a substituent; R3 is alkyl, cycloalkyl, or a combination thereof; and m is 1 or 2. OLEDs, consumer products, and formulations including the compound are also disclosed.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: A compound that has the structure according to Formula M(LA)x(LB)y(LC)z is disclosed. In Formula M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is and OLEDs and formulations containing these compounds are disclosed. In Formula M(LA)x(LB)y(LC)z: M is a metal; x is 1 or 2; X1-X4 and A1-A8 are C or N; at least one of A1-A8 is N; X is O, S, or Se; two adjacent RB form a six-member aromatic ring E fused to ring B; and each RA-RE and R1-R4 is independently hydrogen or a substituent.